Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2021 at "Drugs"
DOI: 10.1007/s40265-021-01650-7
Abstract: Ofatumumab (Kesimpta ® ) is a fully human anti-CD20 monoclonal antibody that can be self-administered by patients and is approved in several countries worldwide for the treatment of relapsing forms of multiple sclerosis (MS). In… read more here.
Keywords: generally manageable; relapsing forms; forms multiple; treatment ... See more keywords
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "Multiple sclerosis"
DOI: 10.1177/13524585211000280
Abstract: BACKGROUND Disease-modifying therapies (DMTs) can reduce the risk of disability worsening in patients with relapsing forms of multiple sclerosis (RMS). High-efficacy DMTs can lead to confirmed or sustained disability improvement (CDI and SDI). OBJECTIVE AND… read more here.
Keywords: relapsing forms; forms multiple; disability; disability improvement ... See more keywords
Ofatumumab for relapsing forms of multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2022 at "Drugs of today"
DOI: 10.1358/dot.2022.58.1.3353168
Abstract: In recent years, B cells have been extensively studied as a therapeutic target in multiple sclerosis (MS). Particularly, anti-CD20 monoclonal antibodies (MAbs) such as rituximab or ocrelizumab have proven to be effective in treating various… read more here.
Keywords: relapsing forms; anti cd20; forms multiple; ofatumumab relapsing ... See more keywords
Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
Sign Up to like & getrecommendations! Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s236926
Abstract: Abstract Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disorder of the central nervous system. Disease-modifying drugs (DMDs) and subsequent adherence are crucial for preventing reversible episodes of neurological dysfunction and delayed onset… read more here.
Keywords: fumarate novel; relapsing forms; therapy; diroximel fumarate ... See more keywords